Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice

Background: Calcific aortic valve disease (CAVD) is a significant cause of morbidity and mortality among elderly people. However, no effective medications have been approved to slow or prevent the progression of CAVD. Here, we examined the effect of liraglutide on aortic valve stenosis. Methods: Mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yangzhao, Yuan, Zhaoshun, Wang, Min, Zhang, Zhiyuan, Tan, Changming, Yu, Jiaolian, Bi, Yanfeng, Liao, Xiaobo, Zhou, Xinmin, Ali Sheikh, Md Sayed, Yang, Dafeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531705/
https://www.ncbi.nlm.nih.gov/pubmed/37754815
http://dx.doi.org/10.3390/jcdd10090386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531705/
https://www.ncbi.nlm.nih.gov/pubmed/37754815
http://dx.doi.org/10.3390/jcdd10090386

Ejemplares similares